Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01276821Phase 4Completed
Phase 4, randomised, double-blind trial of hypertonic saline in bronchiolitis (2 arms). Primary endpoint: Mean Change in Clinical Severity Score at 2 hours. Started Jan 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01276821.